Jan 9
|
Bayer plans US expansion despite blood thinner drug setback
|
Jan 8
|
Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial
|
Jan 8
|
Bayer (BAYRY) Elinzanetant Meets Goals in Late-Stage Studies
|
Jan 5
|
Bayer Investor Harris Sees Potential in Breakup of German Conglomerate
|
Jan 5
|
Argentina Pushes to Get Out of Farming Time Warp With Better GMO Seeds
|
Dec 29
|
Bayer (BAYRY) Loses 28% in 2023: What to Expect in 2024?
|
Dec 23
|
Bayer wins latest Roundup cancer trial, ending losing streak
|
Dec 18
|
Monsanto hit with $857 million verdict over PCBs in Washington state school
|
Dec 7
|
20 Real Examples Of Genetically Modified Organisms
|
Dec 6
|
UPDATE 2-Bayer ordered to pay $3.5 million in latest Roundup weedkiller trial
|
Dec 6
|
Bayer ordered to pay $3.5 million in latest Roundup weedkiller trial
|
Dec 3
|
15 Countries that Produce the Most Genetically Modified Crops
|
Dec 3
|
The Race to Save Ketchup: Building a Tomato for a Hotter World
|
Nov 28
|
Bayer Sees No Quick Fixes After Bankers Game Out Breakup
|
Nov 26
|
Bayer chief blames thin drug pipeline on ‘years of under-investment’
|
Nov 25
|
Bayer CEO Says Breakup Wouldn’t Fix All of the Company’s Ills
|
Nov 24
|
Bayer’s Outlook Lowered by Moody’s on ‘Credit Negative Events’
|
Nov 24
|
Morning Brew: iRobot Surges on Amazon Deal Approval, Tesla Eyes India Factory
|
Nov 13
|
Bayer Pulling Lymphoma Drug Aliqopa From U.S.
|
Nov 10
|
U.S. Stocks Are Relatively Pricey. Here Are 3 Bargains From Europe.
|